Bioengineering
ForteBio Launches Two Revolutionary High-Throughput, Label-Free Instruments: the Octet(R) RED384 and the Octet QK384
Published in Biotech Business Week, July 6th, 2009
ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, announced that it has launched two next-generation instruments: the Octet RED384 for protein, peptide, small molecule and fragment screening; and the Octet QK384 for protein and antibody assays. The new instruments will debut this week at the 2009 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology conference in Seattle, Washington, and will provide life science researchers with unprecedented throughput, speed, flexibility and cost-efficiency when using the company's Octet platform.
The Octet RED384...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- American Association for Cancer Research
Green tea may affect prostate cancer progression - American Cancer Society
Caucasians are at higher risk of developing Ewing's sarcoma than other races - BioMed Central
A new take on growth factor signaling in tamoxifen resistance - BioMed Central
American elderly thrash English at 'brain training' test - BioMed Central
Larvae shun the light - BioMed Central
People think bottled water is healthy ... sort of - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
